Exploring the link between gut bacteria and antibiotic resistance

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between intestinal microbiota and antimicrobial resistance, particularly in patients who have experienced a stroke. It aims to understand how gut bacteria may influence the risk of acquiring multi-drug resistant organisms, which are a significant public health threat. By examining patients within two days of hospital admission for acute ischemic or hemorrhagic stroke, the study seeks to gather data that could inform strategies to combat antimicrobial resistance. The research highlights the urgent need to address the growing issue of drug-resistant infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 years or above, and
* Radiological evidence of acute ischaemic or hemorrhagic stroke
* Within two days of hospital admission

Exclusion Criteria:

* Use of antibiotics within 4 weeks prior to the time of screening
* Underlying gastrointestinal diseases, including gastrointestinal malignancy, inflammatory bowel disease, resection of small or large bowel
* Pregnancy

Where it's running

• Prince of Wales Hospital
  Sha Tin, Hong Kong Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using integron tests to guide first-line antibiotics for non-severe UTI in adults

  This trial tests whether detecting integrons in urine can help doctors choose appropriate antibiotics for adults with non-severe urinary tract infections who had a resistant gram-negative infection in the past.

  Recruiting University Hospital, Limoges · Chambray-lès-Tours and 6 other locations · NCT07675018

• How HIV Treatment Changes Affect Hidden Drug Resistance

  Researchers will see if changing HIV treatment in people with fully suppressed virus reveals hidden drug resistance in proviral DNA.

  Recruiting Chinese University of Hong Kong · Hong Kong, Hong Kong · NCT07643948

• Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia

  This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.

  Recruiting Chinese University of Hong Kong · Hong Kong, Hong Kong · NCT07921173

• Ultrasound-guided microwave ablation for benign thyroid nodules

  This study tests whether using ultrasound-guided microwave ablation to shrink benign thyroid nodules under local anesthesia is safe and effective, compared with traditional surgery.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07906821

• Romiplostim added to standard ESA therapy in adults on hemodialysis with ESA-resistant anemia

  This phase 2 study tests whether adding romiplostim to ongoing ESA treatment is safe and tolerable for adults on dialysis whose anemia does not respond well to ESAs.

  Recruiting Phase 2 Chinese University of Hong Kong · Hong Kong · NCT07854561

• Metomidate PET-CT vs Usual Care for Primary Aldosteronism

  This study tests whether [11C] metomidate PET-CT can help orient treatment for people with primary aldosteronism compared with the usual adrenal venous sampling approach.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07814105

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.